Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL.

about

Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL.

Item

http://www.wikidata.org/entity/Q38975200

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL.

@en

type

Item

label

Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL.

@en

prefLabel

Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL.

@en

P1476

Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL.

@en

P2093

Ana África Martín

http://www.w3.org/2001/XMLSchema#string

Felipe de Arriba

http://www.w3.org/2001/XMLSchema#string

Josefina Galende

http://www.w3.org/2001/XMLSchema#string

José-Ángel Hernández

http://www.w3.org/2001/XMLSchema#string

Laura Lacalle

http://www.w3.org/2001/XMLSchema#string

María Hernández-Sanchez

http://www.w3.org/2001/XMLSchema#string

María Lourdes Hermosín

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

TP53 mutation and survival in chronic lymphocytic leukemia.

Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial.

Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy.

Genomic aberrations and survival in chronic lymphocytic leukemia

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data.

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.

Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?

A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.

P304

142-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EJH.12812

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cristina Robledo

Isabel González-Gascón y Marín

Natalia de las Heras

Jose-Angel Hernandez-Rivas

J M Hernandez

Ana Eugenia Rodríguez-Vicente

P577

2016-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27717146

http://www.w3.org/2001/XMLSchema#string